Search
for
Sort by
Research 121–150 of 1000+
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Hormonal trends in patients suffering from long COVID symptoms
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic
- Eflúvio telogeno pós-COVID
- Finding Long-COVID: Temporal Topic Modeling of Electronic Health Records from the N3C and RECOVER Programs
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- It’s X-Related: Biological Bases of Increased COVID-19 Morbidity and Mortality in Men
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Is there a POST‐COVID dermatological syndrome? The integrated dermato‐infectious disease experience of a single centre
- Post-COVID Telogen Effluvium.
- Severe Acute Respiratory Syndrome (SARS)
- Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
- Long-COVID symptoms after multisystem inflammatory syndrome in children during different pandemic waves
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Telogen effluvium in the new SARS‐CoV‐2 era
- Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- Long COVID-19 Effects (Chronic Covid-19 syndrome) in Nepalese Cohort recovered from SARS-CoV-2 infection
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Androgens in SARS-CoV-2 Coronavirus Infections
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target